← United States · Coverage record
US · SEC FORM 4
Elevance Health, Inc.
ELV · NYSE · CIK 0001156039 · Healthcare · Healthcare Plans
INSIDER SIGNAL
2 buyers · 3 purchase transaction lines · $1.4M gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Role scores low · most senior buyer: President and CEO (CEO, chair and 10% owners score lowest)
- ⚠ Purchase activity is becoming less recent
- ⚠ Buying conviction is reduced by concurrent selling
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Purchase breadth & concentration
Roles in the peak window: Director, President and CEO. Concentration uses priced qualifying P lines only and does not change the saved score.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 9 additional owner(s) remain in Form 4 evidence.
SIGNAL HISTORY
Latest recorded score
- 48.3
- 48.2
- 48.1
- 48.0
- 48.0
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -0.9%
- 3M
- -2.9%
- 6M
- +32.5%
- 12M
- +13.9%
Volatility & liquidity
- Volatility
- 36.2%
- Beta
- —
- Avg daily value
- USD 497.6M
Valuation
- Market cap
- USD 89.5B
- P/E
- 15.8×
Fundamentals
- Profit margin
- 2.8%
- ROE
- 12.9%
- Industry
- Healthcare Plans
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, P/E, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-10 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 4,854,598
- Previous report
- 5,335,623
- Avg daily volume
- 1,236,911
- Days to cover
- 3.9
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | PERU RAMIRO G | Purchase (P) | Common Stock | 1,000 | USD 366.05 | USD 366,050 | SEC filing ↗ |
| 2026-07-17 | BOUDREAUX GAIL | Purchase (P) | Common Stock | 2,725 | USD 367.79 | USD 1,002,230 | SEC filing ↗ |
| 2026-03-05 | COLLIS STEVEN H | Purchase (P) | Common Stock | 3,000 | USD 289.84 | USD 869,520 | SEC filing ↗ |
| 2025-08-19 | DeVore Susan D. | Purchase (P) | Common Stock | 1,200 | USD 312.15 | USD 374,580 | SEC filing ↗ |
| 2025-07-18 | BOUDREAUX GAIL | Purchase (P) | Common Stock | 8,500 | USD 286.94 | USD 2,438,951 | SEC filing ↗ |
| 2021-07-23 | Schneider Ryan M. | Purchase (P) | Common Stock | 1,300 | USD 384.36 | USD 499,668 | SEC filing ↗ |
| 2021-02-04 | Schneider Ryan M. | Purchase (P) | Common Stock | 1,700 | USD 296.03 | USD 503,251 | SEC filing ↗ |
| 2020-01-30 | BOUDREAUX GAIL | Purchase (P) | Common Stock | 7,600 | USD 263.70 | USD 2,004,152 | SEC filing ↗ |
Form 4 evidence
61 transaction lines in the latest 365-day window; 470 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Kaye Mark | Tax withholding (F) | Common Stock | 4,161 | USD 386.43 | USD 1,607,935 | SEC filing ↗ |
| 2026-10-02 | Kaye Mark | Award / grant (A) | Common Stock | 2,627 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-03 | Wessling Erin M | Tax withholding (F) | Common Stock | 255 | USD 414.78 | USD 105,769 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Kaye Mark | Tax withholding (F) | Common Stock | 4,161 | USD 386.43 | USD 1,607,935 | SEC filing ↗ |
| 2026-10-02 | Kaye Mark | Award / grant (A) | Common Stock | 2,627 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-03 | Wessling Erin M | Tax withholding (F) | Common Stock | 255 | USD 414.78 | USD 105,769 | SEC filing ↗ |
| 2026-09-02 | Wessling Erin M | Tax withholding (F) | Common Stock | 94 | USD 405.84 | USD 38,149 | SEC filing ↗ |
| 2026-09-02 | Craig Ryan R | Tax withholding (F) | Common Stock | 144 | USD 405.84 | USD 58,441 | SEC filing ↗ |
| 2026-07-17 | PERU RAMIRO G | Purchase (P) | Common Stock | 1,000 | USD 366.05 | USD 366,050 | SEC filing ↗ |
| 2026-07-17 | BOUDREAUX GAIL | Purchase (P) | Common Stock | 2,725 | USD 367.79 | USD 1,002,230 | SEC filing ↗ |
| 2026-06-12 | Penczek Ronald W | Sale (S) | Common Stock | 369 | USD 403.16 | USD 148,766 | SEC filing ↗ |
| 2026-06-11 | Dixon Robert L JR | Sale (S) | Common Stock | 151 | USD 401.77 | USD 60,667 | SEC filing ↗ |
| 2026-05-19 | Penczek Ronald W | Sale (S) | Common Stock | 1,531 | USD 403.13 | USD 617,192 | SEC filing ↗ |
| 2026-05-19 | Penczek Ronald W | Option exercise / conversion (M) | Common Stock | 1,531 | USD 294.30 | USD 450,579 | SEC filing ↗ |
| 2026-05-13 | Schneider Ryan M. | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | SCHULMAN AMY W | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | PERU RAMIRO G | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | Neri Antonio F | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | Jallal Bahija | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | HAY LEWIS III | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | Dixon Robert L JR | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | DeVore Susan D. | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-13 | COLLIS STEVEN H | Award / grant (A) | Common Stock | 563 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-12 | SCHULMAN AMY W | Sale (S) | Common Stock | 26 | USD 287.50 | USD 7,475 | SEC filing ↗ |
| 2026-03-06 | Kendrick Charles Morgan JR | Sale (S) | Common Stock | 3,196 | USD 284.92 | USD 910,604 | SEC filing ↗ |
| 2026-03-05 | COLLIS STEVEN H | Purchase (P) | Common Stock | 3,000 | USD 289.84 | USD 869,520 | SEC filing ↗ |
| 2026-03-03 | Wessling Erin M | Tax withholding (F) | Common Stock | 417 | USD 284.03 | USD 118,441 | SEC filing ↗ |
| 2026-03-03 | Penczek Ronald W | Tax withholding (F) | Common Stock | 37 | USD 284.03 | USD 10,509 | SEC filing ↗ |
| 2026-03-03 | Norwood Felicia F | Tax withholding (F) | Common Stock | 496 | USD 284.03 | USD 140,879 | SEC filing ↗ |
| 2026-03-03 | LAVU RATNAKAR | Tax withholding (F) | Common Stock | 222 | USD 284.03 | USD 63,055 | SEC filing ↗ |
| 2026-03-03 | Kendrick Charles Morgan JR | Tax withholding (F) | Common Stock | 467 | USD 284.03 | USD 132,642 | SEC filing ↗ |
| 2026-03-03 | Kaye Mark | Tax withholding (F) | Common Stock | 353 | USD 284.03 | USD 100,263 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-19 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | ELV |
| CIK | 0001156039 |
| Sector | Healthcare |
| Industry | Healthcare Plans Yahoo Finance |
| SEC SIC | 6324 Hospital & Medical Service Plans |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 470 transaction lines from 2020-01-30 to 2026-10-02 12 P purchase lines · 111 S sale lines · 347 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.